Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537868) titled 'Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction' on April 12.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Triple (Participant, Care Provider, Outcomes Assessor).

Primary Sponsor: October 6 University

Condition: Acute Myocardial Infarction (AMI)

Intervention: Drug: Montelukast 10 Mg Oral Tablet

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 20, 2026

Target Sample Size: 80

To know more, visit https://clinicaltrials...